Yes, a 58-year-old woman can absolutely be considered for liver transplant evaluation
A 58-year-old female should not be disqualified from liver transplant evaluation based on age alone, as chronological age is not a contraindication to transplantation. 1
Age Is Not a Barrier
The most recent EASL 2024 guidelines explicitly state that "a potential candidate for LT should not be disqualified based on age alone" (strong recommendation, consensus) 1. This represents the current standard of care, with both EASL and AASLD emphasizing biological age over chronological age.
At 58 years old, this patient falls well within the typical transplant age range and is actually younger than the growing elderly cohort now being transplanted. Current data shows:
- The proportion of waitlisted patients over age 65 has risen from 8% in 2002 to 17% in 2014 in the US 1
- Even patients over 70 years are increasingly being transplanted successfully 1
- Meta-analysis of 242,487 patients showed elderly recipients (>65 years) had comparable patient mortality (HR 1.26; 95% CI 0.97-1.63; p=0.09) and graft loss compared to younger patients 1
What Actually Matters: Comprehensive Evaluation
Instead of age, the evaluation should focus on a comprehensive assessment including:
- Cardiopulmonary reserve - cardiac stress testing, pulmonary function
- Frailty and sarcopenia status - using standardized metrics like the Liver Frailty Index 1
- Nutritional status - particularly important as BMI alone should not exclude patients 2
- Anatomical and surgical factors - portal vein patency, prior surgeries
- Age-appropriate cancer screening - colonoscopy, mammography, etc. 1
- Mental health status - which is not an absolute contraindication even when serious 2
Important Considerations for Women
Female gender presents specific considerations that require attention:
Women face documented disparities in transplant access despite similar disease severity 1. They experience:
- Higher waitlist mortality than men despite similar MELD scores 3
- Greater frailty burden (13% of the gender mortality gap is mediated by frailty) 3
- Systematic bias from creatinine-based MELD scoring 4, 5
However, these are access issues, not contraindications. The evaluation should use standardized frailty metrics to reduce subjectivity 2, and newer allocation systems are being developed to address gender disparities 1.
Common Pitfalls to Avoid
- Do not use BMI as a sole exclusion criterion - patients with BMI >40 or <18.5 should undergo muscle mass and nutritional screening, but should not be excluded based on BMI alone 2
- Do not let physical frailty alone disqualify - while frailty is a risk factor, it should not be a sole contraindication; use standardized metrics for assessment 2
- Do not assume high MELD (>40) or ACLF are contraindications - these are not absolute contraindications; assess trajectory and probability of acceptable outcome 2
Bottom Line
Proceed with full transplant evaluation for this 58-year-old woman, focusing on biological fitness rather than chronological age. The assessment should be thorough but not exclusionary based on age, with particular attention to frailty assessment using validated tools and comprehensive comorbidity screening appropriate for her age and risk factors.